{"id":17940,"date":"2021-09-20T05:29:34","date_gmt":"2021-09-20T05:29:34","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=79067"},"modified":"2021-09-20T05:29:34","modified_gmt":"2021-09-20T05:29:34","slug":"jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million","status":"publish","type":"post","link":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/","title":{"rendered":"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION)"},"content":{"rendered":"
\n

\"\"<\/p>\n

JEITO CAPITAL <\/strong>BECOMES A KEY PLAYER IN THE FINANCING <\/strong>
\nOF <\/strong>LIFE<\/strong> SCIENCES<\/strong> IN EUROPE WITH THE CLOSING OF JEITO<\/strong> I <\/strong>
\nAT<\/strong> \u20ac534 MIL<\/strong>L<\/strong>ION <\/strong>($63<\/strong>0<\/strong> MILLION)<\/strong><\/p>\n

Jeito<\/em> I <\/em>exceeds target and <\/em>becomes<\/em> the largest European fund dedicated <\/em>
\nto the life<\/em> sciences sector<\/em><\/p>\n

Jeito Capital is dedicated to <\/em>working with <\/em>biotech entrepreneurs<\/em> to provide<\/em>
\nfinancial and <\/em>expert <\/em>support<\/em> in continuity <\/em>to accelerate patients\u2019 access <\/em>
\nto<\/em> groundbreaking therapies<\/em><\/p>\n

Paris, September 20<\/strong>, <\/strong>2021<\/strong> \u2013 Jeito Capital, a rapidly growing, new, independent Private Equity firm dedicated to biotech and biopharma, today announced the final closing of its first fund, Jeito I, at \u20ac534 million ($630 million), exceeding its original target of \u20ac500 million. Jeito I is the largest European fund dedicated to supporting companies in the life sciences sector.<\/p>\n

Jeito Capital is building a strong and diversified portfolio of biotech and biopharma companies primarily based in Europe with global reach, focused on the treatment of life-threatening diseases. Jeito\u2019s unique investment model provides support to entrepreneurs by a multi-talented team of experts integrated in the investment team across the entire drug development value chain, from translational science to market access and commercialization, providing significant capital in continuity, up to \u20ac80 million ($100 million) in a single company.<\/p>\n

Jeito I investments to date include French-based SparingVision and InnoSkel, in the fields of genomic ophthalmology and rare skeletal disorders, respectively, Dutch biotech Neogene Therapeutics in solid tumors, UK-based Pulmocide in severe respiratory diseases, and Swiss-French Alentis Therapeutics in fibrosis and related cancers.<\/p>\n

Jeito I attracted leading global investors including the European Investment Fund (EIF), the American pension fund Teacher Retirement System of Texas (TRS), which has made its first-ever investment into a European fund dedicated to the biotech sector, and Temasek, a global investor headquartered in Singapore with deep experience investing in life sciences.<\/p>\n

Founded and directed by Dr Rafa\u00e8le Tordjman, MD PhD, Jeito Capital was launched in January 2020 and completed a first funding round of \u20ac200 million with the strategic support of investors such as Aviva, AXA, the French public investment bank (BPI), BNP Paribas Fortis, the Caisse des D\u00e9p\u00f4ts et des Consignations (CDC), CNP Assurances, Pro BTP, etc. In the following months Sanofi selected Jeito as its first ever investment into a private French-based fund, investing \u20ac50 million.<\/p>\n

Rafa\u00e8le Tordjman, Founder and <\/strong>CEO<\/strong> of Jeito Capital, <\/strong>said: \u201cWe are <\/em>extremely<\/em> proud<\/em> to have <\/em>closed Jeito <\/em>I<\/em>,<\/em> making it<\/em> the <\/em>largest European fund dedicated to the life<\/em> sciences sector.<\/em> W<\/em>e have <\/em>thus <\/em>e<\/em>xceed<\/em>ed<\/em> our original target<\/em> and have attracted a group of leading <\/em>and divers<\/em>e<\/em> global <\/em>investors, a testament to <\/em>Jeito\u2019s<\/em> unique investment model<\/em> and team<\/em>. I am pleased to welcome<\/em> new investors including the EIF,<\/em> TRS and <\/em>Temasek<\/em> and<\/em> would like to thank our<\/em> existing investors for their unwavering support. <\/em>This <\/em>important<\/em> achievement<\/em> will enable<\/em> Jeito to fulfill its<\/em> mission<\/em>:<\/em> to<\/em> provid<\/em>e<\/em> continuous financial <\/em>support<\/em> and industry expertise to<\/em> talented <\/em>entrepreneurs<\/em> to accelerate the development of <\/em>revolutionary<\/em> t<\/em>herapies<\/em> and guaranteeing patients quicker access to medical innovations<\/em>.\u201d<\/em><\/p>\n

Sabine Dandiguian, Managing Partner<\/strong> of Jeito Capital<\/strong>,<\/strong> added: \u201cThis exceptional fundraising success confirms <\/em>Jeito\u2019s<\/em> investment model driven by Rafa\u00e8le Tordjman<\/em>.<\/em> I am very proud <\/em>to <\/em>have <\/em>be<\/em>en<\/em> part of<\/em> this <\/em>multi-talented<\/em> team <\/em>sinc<\/em>e<\/em> the very beginning <\/em>which, thanks to its expertise <\/em>across<\/em> all stages of compan<\/em>y<\/em> development, <\/em>is able to uncover and support the best<\/em> scientific quality start<\/em>–<\/em>ups in Europe<\/em>, <\/em>with a global <\/em>reach<\/em>.<\/em> Thanks to <\/em>Jeito<\/em>\u2019s<\/em> dynamic <\/em>and collaborative <\/em>team <\/em>we have already<\/em> developed <\/em>a pipeline of<\/em> high-quality deal flow<\/em>. <\/em>W<\/em>e look forward to achieving our<\/em> shared<\/em> ambition<\/em>s<\/em> and<\/em> mak<\/em>ing<\/em> a <\/em>significant and meaningful <\/em>difference <\/em>to<\/em> patients<\/em>\u2019 lives<\/em>.<\/em>\u201d<\/em><\/p>\n

Currency converter: <\/em>\u20ac1 = US<\/em>D<\/em>$<\/em>1.18<\/em> as of 14 September 2021<\/em><\/p>\n

About Jeito Capital<\/strong>
\nJeito Capital is a global leading investment company with a patient benefit driven approach that finances and accelerates the development and growth of ground-breaking medical innovation. Jeito empowers and supports entrepreneurs through its expert, integrated, multi-talented team and through the investment of significant capital to ensure the growth of companies, building market leaders in their respective therapeutic areas with accelerated patients\u2019 access in Europe & the United States. Jeito Capital has \u20ac534 million under management. Jeito Capital is based in Paris with a presence in Europe and the United States. For more information, please visit www.jeito.life, or follow on Twitter @Jeito_life or LinkedIn.<\/p>\n

For more information please contact:<\/strong><\/p>\n\n\n\n
Jeito Capital<\/strong>
\nRafa\u00e8le Tordjman, Founder and CEO
\ncontact@jeito.life<\/a><\/p>\n

Assistant : Marine Beigneux
\nmarine@jeito.life<\/a><\/p>\n

Consilium Strategic Communications <\/strong>(international PR)<\/strong>
\nMary-Jane Elliott \/ Melissa Gardiner \/ Davide Salvi\/ Kris Lam
\nJeito@consilium-comms.com<\/a><\/p>\n

Tilder<\/strong> (French PR)<\/strong><\/p>\n

Marion Bougeard
\nm<\/a>.bougeard@tilder.com<\/a><\/td>\n

\n

Tel: +33 6 35 36 35 00<\/p>\n

Tel: +44 (0) 20 3709 5700<\/p>\n

Tel: +33 (0) 6 76 73 57 31<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

Please click here<\/a>\u00a0to see the full release in French<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) Jeito I exceeds target and becomes the largest European fund dedicated to the life sciences sector Jeito Capital is dedicated to working with biotech entrepreneurs to provide financial and expert [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"yoast_head":"\nJEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) - Myanmar Newswire<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) - Myanmar Newswire\" \/>\n<meta property=\"og:description\" content=\"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) Jeito I exceeds target and becomes the largest European fund dedicated to the life sciences sector Jeito Capital is dedicated to working with biotech entrepreneurs to provide financial and expert [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/\" \/>\n<meta property=\"og:site_name\" content=\"Myanmar Newswire\" \/>\n<meta property=\"article:published_time\" content=\"2021-09-20T05:29:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b\"},\"headline\":\"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION)\",\"datePublished\":\"2021-09-20T05:29:34+00:00\",\"dateModified\":\"2021-09-20T05:29:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/\"},\"wordCount\":800,\"publisher\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/\",\"url\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/\",\"name\":\"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) - Myanmar Newswire\",\"isPartOf\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76\",\"datePublished\":\"2021-09-20T05:29:34+00:00\",\"dateModified\":\"2021-09-20T05:29:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage\",\"url\":\"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76\",\"contentUrl\":\"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/myanmarnewswire.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Press Releases\",\"item\":\"https:\/\/myanmarnewswire.com\/category\/press-releases\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/myanmarnewswire.com\/#website\",\"url\":\"https:\/\/myanmarnewswire.com\/\",\"name\":\"Myanmar Newswire\",\"description\":\"Latest News, Right Away!\",\"publisher\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/myanmarnewswire.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/myanmarnewswire.com\/#organization\",\"name\":\"Myanmar Newswire\",\"url\":\"https:\/\/myanmarnewswire.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png\",\"contentUrl\":\"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png\",\"width\":400,\"height\":54,\"caption\":\"Myanmar Newswire\"},\"image\":{\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/myanmarnewswire.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\/\/myanmarnewswire.com\/author\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) - Myanmar Newswire","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/","og_locale":"en_US","og_type":"article","og_title":"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) - Myanmar Newswire","og_description":"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) Jeito I exceeds target and becomes the largest European fund dedicated to the life sciences sector Jeito Capital is dedicated to working with biotech entrepreneurs to provide financial and expert [\u2026]","og_url":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/","og_site_name":"Myanmar Newswire","article_published_time":"2021-09-20T05:29:34+00:00","og_image":[{"url":"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#article","isPartOf":{"@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/"},"author":{"name":"admin","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b"},"headline":"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION)","datePublished":"2021-09-20T05:29:34+00:00","dateModified":"2021-09-20T05:29:34+00:00","mainEntityOfPage":{"@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/"},"wordCount":800,"publisher":{"@id":"https:\/\/myanmarnewswire.com\/#organization"},"image":{"@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/","url":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/","name":"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION) - Myanmar Newswire","isPartOf":{"@id":"https:\/\/myanmarnewswire.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage"},"image":{"@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage"},"thumbnailUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76","datePublished":"2021-09-20T05:29:34+00:00","dateModified":"2021-09-20T05:29:34+00:00","breadcrumb":{"@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#primaryimage","url":"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76","contentUrl":"https:\/\/ci3.googleusercontent.com\/proxy\/XaYuXaGlRAlfGnpDp_RCaMXAw3FwgaKKatPHfG29kwmxkrCJpB4opzGKanLElXqzq2OLs4t1YXokkRu3ueNnMz1xXOOljsqmUJi7Yzn5TVLrL9KbXBXL_E0-K3WhbjTwZpv52QgXRW0b=s0-d-e1-ft#https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/3282f095-80fe-48e2-8991-77194e52dd76"},{"@type":"BreadcrumbList","@id":"https:\/\/myanmarnewswire.com\/jeito-capital-becomes-a-key-player-in-the-financing-of-life-sciences-in-europe-with-the-closing-of-jeito-i-at-e534-million-630-million\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/myanmarnewswire.com\/"},{"@type":"ListItem","position":2,"name":"Press Releases","item":"https:\/\/myanmarnewswire.com\/category\/press-releases\/"},{"@type":"ListItem","position":3,"name":"JEITO CAPITAL BECOMES A KEY PLAYER IN THE FINANCING OF LIFE SCIENCES IN EUROPE WITH THE CLOSING OF JEITO I AT \u20ac534 MILLION ($630 MILLION)"}]},{"@type":"WebSite","@id":"https:\/\/myanmarnewswire.com\/#website","url":"https:\/\/myanmarnewswire.com\/","name":"Myanmar Newswire","description":"Latest News, Right Away!","publisher":{"@id":"https:\/\/myanmarnewswire.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/myanmarnewswire.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/myanmarnewswire.com\/#organization","name":"Myanmar Newswire","url":"https:\/\/myanmarnewswire.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/","url":"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png","contentUrl":"https:\/\/myanmarnewswire.com\/wp-content\/uploads\/2017\/08\/logo-2.png","width":400,"height":54,"caption":"Myanmar Newswire"},"image":{"@id":"https:\/\/myanmarnewswire.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/person\/f449613780cb879df549f28a5d10715b","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/myanmarnewswire.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/myanmarnewswire.com\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/posts\/17940"}],"collection":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/comments?post=17940"}],"version-history":[{"count":0,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/posts\/17940\/revisions"}],"wp:attachment":[{"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/media?parent=17940"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/categories?post=17940"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/myanmarnewswire.com\/wp-json\/wp\/v2\/tags?post=17940"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}